Butyricimonas virosa AM16-14 attenuates dextran sulfate sodium-induced colitis and shifts mouse fecal metabolomic trajectories
Frontiers in Microbiology · 11.11.2026 · 17
DOI: 10.3389/fmicb.2026.1931907 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 11.11.2026. Verfasst von Jinlong Yang und 10 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ulcerative colitis (UC) involves epithelial injury, inflammation, and microbiota-linked metabolism. We evaluated Butyricimonas virosa AM16-14 in an acute dextran sulfate sodium (DSS) colitis mouse experiment, resolved its complete genome, analyzed human UC microbiome data as ecological context, and examined fecal liquid chromatography-mass spectrometry (LC–MS) profiles in positive- and negative-ion modes. AM16-14 carried a 5.00 Mb circular genome with 42.95% GC content and 4,126 predicted coding sequences. Compared with DSS alone, AM16-14-treated mice showed higher final body weight, a lower disease activity index (DAI), longer colons, reduced histological injury, stronger Alcian blue mucin staining, and lower tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6); interleukin-1beta (IL-1beta) and interleukin-10 (IL-10) did not change significantly. The human analysis associated B. virosa with lower focal network connectivity in UC. Positive-ion profiles identified recovery-oriented feature shifts and two dominant recovery trajectories. Complementary negative-ion analysis retained 1,079 features. Complementary genomic screens yielded nine loci associated with antimicrobial resistance (AMR), virulence-associated reference homologies, and one final predicted provirus. A cluster of four AMR-associated loci occurred near transposase annotations. These findings support AM16-14 as a complete-genome-resolved microbiota-directed candidate strain that attenuates multiple acute mouse colitis readouts.
Zitieren
APA
Yang, J., Lin, Z., Lu, X., Ma, J., Wang, H., Yang, Y., Yang, Z., Li, S., Zou, Y., Lai, J., & Wei, S. (2026). Butyricimonas virosa AM16-14 attenuates dextran sulfate sodium-induced colitis and shifts mouse fecal metabolomic trajectories. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1931907
Vancouver
Yang J, Lin Z, Lu X, Ma J, Wang H, Yang Y, et al. Butyricimonas virosa AM16-14 attenuates dextran sulfate sodium-induced colitis and shifts mouse fecal metabolomic trajectories. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1931907
BibTeX
@article{Yang2026,
author = {Yang, Jinlong and Lin, Zhiyin and Lu, Xiaohong and Ma, Jiayi and Wang, Haoyu and Yang, Yining and Yang, Zizhen and Li, Shangyong and Zou, Yuanqiang and Lai, Jianghua and Wei, Shuguang},
title = {Butyricimonas virosa AM16-14 attenuates dextran sulfate sodium-induced colitis and shifts mouse fecal metabolomic trajectories},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {17},
doi = {10.3389/fmicb.2026.1931907}
}
EUVIMED